Form D · Biotechnology
Carcinotech Ltd.
Scotland, X0 · CIK 0002005300
Offering snapshot reported Jan 3, 2024 · SEC filing
- Reported sold
- $508K Offering amount: $508K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2024 | Initial | $508,454 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-501419
Source: Form D, filed Jan 3, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ishani Malhotra | Director, Executive |
| Albert Nicholl | Director |
| Ian David Waddell | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Roslin Innovation Centre Easter Bush Campus, Edinburgh Midlothian
Scotland, X0, EH25 9RG
Scotland, X0, EH25 9RG